Page last updated: 2024-08-23

pregnanolone and Epilepsy Syndromes

pregnanolone has been researched along with Epilepsy Syndromes in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Aimetti, AA; Amin, S; Bahi-Buisson, N; Benke, TA; Cross, JH; Demarest, ST; Devinsky, O; Fleming, TR; Gasior, M; Knight, EMP; Olson, HE; Specchio, N	1
Samanta, D	1

Reviews

1 review(s) available for pregnanolone and Epilepsy Syndromes

Article	Year
PCDH19-Related Epilepsy Syndrome: A Comprehensive Clinical Review. Pediatric neurology, 2020, Volume: 105 Topics: Animals; Behavioral Symptoms; Cadherins; Epileptic Syndromes; Humans; Intellectual Disability; Pregnanolone; Protocadherins	2020

Trials

1 trial(s) available for pregnanolone and Epilepsy Syndromes

Article	Year
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial. The Lancet. Neurology, 2022, Volume: 21, Issue:5 Topics: Child; Child, Preschool; Double-Blind Method; Epileptic Syndromes; Humans; Infant; Pregnanolone; Prospective Studies; Protein Serine-Threonine Kinases; Seizures; Spasms, Infantile; Treatment Outcome	2022

Article

Year

Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial.

The Lancet. Neurology, 2022, Volume: 21, Issue:5

Topics: Child; Child, Preschool; Double-Blind Method; Epileptic Syndromes; Humans; Infant; Pregnanolone; Prospective Studies; Protein Serine-Threonine Kinases; Seizures; Spasms, Infantile; Treatment Outcome

2022